Dr. Jane Sunmi Kang, MD

Dr. Kang practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Kang's NPI, 1114124898, was assigned on June 27, 2007. Dr. Kang graduated from Albert Einstein College of Medicine in 2004. Dr. Kang holds New York license 251475.

Dr. Kang's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Kang's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Kang is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Kang to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kang is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kang's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint pain, lupus, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Kang treats.

CMS data shows 505 Medicare services from Dr. Kang across 4 procedure codes in 2024, for 145 Medicare patients. Medicare paid $38,609 for them. Every service was in an office.

CMS counts 145 Medicare patients who saw Dr. Kang in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high cholesterol, and 74% have arthritis. 24% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 62, with 70% women.

In 2024, Dr. Kang wrote 1,253 Medicare Part D claims for 186 patients. 80% of them were for generic drugs. CMS names the drug for 1,140 of them, across 21 drugs with 11 or more claims each, at $1,404,009 in total drug cost. In 2023, CMS named 1,080 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kang for performance year 2024, reported through an alternative payment model (APM). Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth.

Dmand AI links 4 papers to Dr. Kang, published from 2015 to 2024. Dr. Kang's most frequent co-authors are Juliet Brause Aizer, MD, MPH, Anne Ruth Bass, MD and Joan M. Bathon, MD.

Dmand AI lists 2 awards for Dr. Kang, most recently ACR Fellow in 2012.

Dr. Kang graduated from Albert Einstein College of Medicine in 2004. Dr. Kang is a member of ACR.

Dr. Kang is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.